Why Your Acyclovir Prescription Looks Different From Everyone Else's

If you have ever compared your acyclovir prescription with a friend or family member who also takes the medication, you may have noticed something puzzling: the doses, the frequency, and even the duration of treatment can differ considerably. That discrepancy is not a mistake. Acyclovir dosing is a carefully calibrated process, shaped by the specific virus causing your infection, the severity of your symptoms, your kidney health, and your age. Understanding why your prescription looks the way it does is one of the most empowering steps you can take as a patient.

How Acyclovir Works — And Why It Matters for Dosing

Before examining specific dosage ranges, it helps to understand the basic mechanism behind acyclovir. The drug is a synthetic nucleoside analogue, meaning it mimics a building block that viruses need to replicate their genetic material. Once inside an infected cell, acyclovir is converted into an active form that interferes with the virus's ability to copy itself. Crucially, this activation process is far more efficient inside virus-infected cells than in healthy ones, which is why the medication is relatively selective and well-tolerated.

Because acyclovir is primarily eliminated through the kidneys, the amount your body can process — and therefore how much you need to take — depends heavily on how well your kidneys are functioning. This is a central theme in acyclovir dosing and one we will return to throughout this guide.

Dosing for Herpes Simplex Virus Type 1 (HSV-1)

HSV-1 is most commonly associated with oral herpes, including cold sores and fever blisters, though it can also cause genital infections. For initial outbreaks of oral HSV-1, healthcare providers may prescribe acyclovir at 200 mg taken five times daily, or alternatively 400 mg three times daily, for seven to ten days. Topical acyclovir cream is also available for cold sores, though oral formulations are generally considered more effective for managing symptoms systemically.

For patients who experience frequent recurrences — typically defined as six or more outbreaks per year — a daily suppressive regimen may be recommended. Suppressive therapy typically involves 400 mg taken twice daily on an ongoing basis. The goal here is not to cure the infection, which remains latent in nerve tissue, but to reduce the frequency and severity of flare-ups.

Dosing for Herpes Simplex Virus Type 2 (HSV-2)

Genital herpes caused by HSV-2 follows a similar dosing framework but often involves higher doses or longer treatment windows, particularly for initial episodes. A first-time genital herpes outbreak can be significantly more severe than subsequent ones, and treatment typically runs for seven to ten days. Standard oral dosing for an initial episode is 400 mg three times daily or 200 mg five times daily.

For recurrent episodes, a shorter course is usually sufficient — often five days. Suppressive therapy for HSV-2 mirrors the approach used for HSV-1: 400 mg twice daily. Patients in discordant relationships, where one partner has HSV-2 and the other does not, may be advised to continue suppressive therapy indefinitely to reduce transmission risk, a decision that should be made collaboratively with a healthcare provider.

Dosing for Shingles (Herpes Zoster)

Shingles, caused by the reactivation of the varicella-zoster virus (VZV), requires substantially higher doses of acyclovir than HSV infections. The standard adult regimen is 800 mg taken five times daily for seven to ten days. This higher dose reflects the fact that VZV is somewhat less sensitive to acyclovir than HSV, requiring greater drug concentrations to achieve a meaningful antiviral effect.

Timing is particularly critical with shingles. Treatment started within 72 hours of rash onset tends to produce the best outcomes, including reduced pain duration and lower risk of postherpetic neuralgia — a persistent nerve pain that can linger for months after the rash resolves. If you suspect shingles, contacting your provider promptly is essential.

Kidney Function and Dose Adjustments

The kidneys are responsible for clearing acyclovir from the body, and this has significant implications for patients with reduced kidney function. When kidney filtration is impaired — measured clinically as a reduced creatinine clearance (CrCl) — acyclovir can accumulate to higher-than-intended levels, raising the risk of side effects including nausea, neurological symptoms, and in severe cases, kidney damage itself.

For patients with mild to moderate kidney impairment, providers typically reduce the dose, extend the interval between doses, or both. For example, a patient with a CrCl below 10 mL/min may require dosing only every 12 hours rather than every four to eight hours. Patients on hemodialysis require special consideration, as dialysis removes acyclovir from the bloodstream and supplemental dosing after sessions may be necessary.

If you have a history of kidney disease, diabetes, high blood pressure, or are taking other medications that affect kidney function, it is important to inform your prescribing provider before starting acyclovir.

Age-Related Considerations

Age influences acyclovir dosing in two important directions. In pediatric patients, doses are often calculated based on body weight (in milligrams per kilogram) rather than fixed amounts, ensuring that smaller bodies receive appropriately scaled treatment. For conditions like chickenpox in otherwise healthy children, doses are typically lower and treatment duration shorter than in adults.

Older adults, on the other hand, often experience a natural decline in kidney function as part of aging — even in the absence of diagnosed kidney disease. This means that a 75-year-old patient may require a lower dose than a 35-year-old patient with the same infection, not because the virus behaves differently, but because their kidneys process the drug more slowly. Providers should take current kidney function into account when prescribing for elderly patients, and patients in this age group should be alert to any unusual symptoms during treatment.

Intravenous Acyclovir: When Oral Treatment Is Not Enough

For severe infections — including herpes encephalitis, neonatal herpes, or disseminated VZV in immunocompromised individuals — intravenous (IV) acyclovir is the standard of care. IV administration delivers much higher drug concentrations than oral dosing can achieve and is administered in a hospital or clinical setting. Doses and infusion schedules for IV acyclovir vary considerably depending on the condition being treated and the patient's kidney function, and are managed by the treating medical team.

Questions Worth Asking Your Provider

Armed with this background knowledge, patients are better positioned to have productive conversations with their healthcare providers. Consider asking:

• Why was my specific dose and frequency chosen?
• Should my kidney function be tested before or during treatment?
• How long should I expect to remain on suppressive therapy?
• What symptoms should prompt me to contact you during my course of treatment?
• Are there any medications I currently take that might interact with acyclovir?

Your prescription reflects a clinical judgment about what will work best for your particular situation. Understanding the reasoning behind that judgment — rather than simply following instructions without context — leads to better adherence, fewer missed doses, and ultimately more effective treatment.